Novelix Pharmaceuticals Limited (BOM:536565)
India flag India · Delayed Price · Currency is INR
66.23
-3.77 (-5.39%)
At close: Oct 5, 2026

Novelix Pharmaceuticals Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-29.596.791.182.7528.9
Short-Term Investments
---2525-
Trading Asset Securities
---8.733.911.19
Cash & Short-Term Investments
29.5929.596.7934.9131.6630.09
Cash Growth
335.99%335.99%-80.56%10.26%5.22%29.25%
Accounts Receivable
-589.62181.370.131.912.32
Other Receivables
-22.941.582.833.663.89
Receivables
-710.86253.182.976.3420.38
Inventory
-144.328.433.214.298.77
Prepaid Expenses
--0.180.010.130.08
Other Current Assets
-4.350.750.2--0
Total Current Assets
-889.11269.3341.342.4359.31
Property, Plant & Equipment
-15.221.861.181.744.55
Long-Term Investments
-0.430.4330.6427.754.22
Other Intangible Assets
-19.2-000.11
Long-Term Deferred Tax Assets
-0.270.450.540.650.66
Other Long-Term Assets
--00--18.54
Total Assets
-924.23272.0773.6572.5787.38

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-402.5492.010.030.548.83
Accrued Expenses
-5.293.360.070.070.09
Current Portion of Long-Term Debt
-----0.34
Current Income Taxes Payable
-8.30.3---
Other Current Liabilities
-43.22100.010.05
Total Current Liabilities
-459.3596.670.10.629.29
Long-Term Debt
-----1.31
Total Liabilities
-459.3596.670.10.6210.6

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-210.8599.5818181
Additional Paid-In Capital
-247.2394.6512.1512.1512.15
Retained Earnings
-6.81-18.76-19.6-24.32-22.74
Comprehensive Income & Other
----3.123.63
Total Common Equity
464.88464.88175.3973.5571.9574.04
Minority Interest
-----2.74
Shareholders' Equity
464.88464.88175.3973.5571.9576.78
Total Liabilities & Equity
-924.23272.0773.6572.5787.38

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
43.22----1.65
Net Cash (Debt)
-13.6329.596.7934.9131.6628.44
Net Cash Growth
-335.99%-80.56%10.26%11.31%22.18%
Net Cash Per Share
-0.561.400.683.353.913.51
Filing Date Shares Outstanding
24.0628.479.958.18.18.1
Total Common Shares Outstanding
24.0621.099.958.18.18.1
Working Capital
-429.76172.6641.241.8150.02
Book Value Per Share
22.0522.0517.639.088.889.14
Tangible Book Value
445.68445.68175.3973.5571.9573.93
Tangible Book Value Per Share
21.1421.1417.639.088.889.13
Buildings
-1.431.431.431.431.43
Machinery
-27.2512.9111.8512.0414.54